InfuSystem Holdings, IncINFUEarnings & Financial Report
InfuSystem Holdings, Inc. is a U.S.-headquartered healthcare provider specializing in infusion therapy solutions. It supplies programmable infusion pumps, matching disposable medical consumables, and professional clinical support services, serving oncology clinics, home healthcare providers, and acute care facilities across North America.
Revenue
$36.5M
Gross Profit
$20.8M
Operating Profit
$3.8M
Net Profit
$2.3M
Gross Margin
57.1%
Operating Margin
10.4%
Net Margin
6.2%
YoY Growth
3.3%
EPS
$0.11
InfuSystem Holdings, Inc Q3 FY2025 Financial Summary
InfuSystem Holdings, Inc reported revenue of $36.5M (up 3.3% YoY) for Q3 FY2025, with a net profit of $2.3M (up 25.0% YoY) (6.2% margin). Cost of goods sold was $15.7M, operating expenses totaled $17.0M.
Key Financial Metrics
| Total Revenue | $36.5M |
|---|---|
| Net Profit | $2.3M |
| Gross Margin | 57.1% |
| Operating Margin | 10.4% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
InfuSystem Holdings, Inc Q3 FY2025 revenue of $36.5M breaks down across 3 segments, led by Patient Services at $20.2M (55.4% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Patient Services | $20.2M | 55.4% |
| Device Solutions | $14.1M | 38.7% |
| Other | $2.1M | 5.9% |
InfuSystem Holdings, Inc Revenue by Segment — Quarterly Trend
InfuSystem Holdings, Inc revenue by segment across the last 4 reported quarters, showing how each business line (such as Patient Services and Device Solutions) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Patient Services | $20.0M | $20.2M | $19.3M | $18.7M |
| Device Solutions | $14.4M | $14.1M | $14.5M | $13.9M |
| Other | $1.9M | $2.1M | $2.2M | $2.1M |
InfuSystem Holdings, Inc Annual Revenue by Year
InfuSystem Holdings, Inc annual revenue history includes year-by-year totals (for example, 2025 revenue was $143.4M).
| Year | Annual Revenue |
|---|---|
| 2025 | $143.4M |
| 2024 | $134.9M |
| 2023 | $125.8M |
| 2022 | $109.9M |
InfuSystem Holdings, Inc Quarterly Revenue & Net Profit History
InfuSystem Holdings, Inc results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $36.2M | +7.0% | N/A | N/A |
| Q3 FY2025 | $36.5M | +3.3% | $2.3M | 6.2% |
| Q2 FY2025 | $36.0M | +6.8% | $2.6M | 7.2% |
| Q1 FY2025 | $34.7M | +8.5% | $-267.0K | -0.8% |
| Q4 FY2024 | $33.8M | +6.5% | N/A | N/A |
| Q3 FY2024 | $35.3M | +10.7% | $1.8M | 5.1% |
| Q2 FY2024 | $33.7M | +6.2% | $717.0K | 2.1% |
| Q1 FY2024 | $32.0M | +5.4% | $-1.1M | -3.5% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $32.0M | $33.7M | $35.3M | $33.8M | $34.7M | $36.0M | $36.5M | $36.2M |
| YoY Growth | 5.4% | 6.2% | 10.7% | 6.5% | 8.5% | 6.8% | 3.3% | 7.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $104.8M | $108.5M | $105.3M | $103.6M | $104.3M | $100.8M | $98.9M | $100.6M |
| Liabilities | $52.6M | $55.0M | $49.8M | $46.1M | $49.1M | $46.3M | $43.4M | $43.2M |
| Equity | $52.3M | $53.5M | $55.5M | $57.5M | $55.1M | $54.5M | $55.5M | $57.3M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $377000 | $2.3M | $9.8M | $7.9M | $1.8M | $7.0M | $8.5M | $7.1M |